AmInvest Research Reports

Petronas Chemicals Group - No Covid-19 impact yet

AmInvest
Publish date: Fri, 28 Feb 2020, 10:15 AM
AmInvest
0 9,388
An official blog in I3investor to publish research reports provided by AmInvest research team.

All materials published here are prepared by AmInvest. For latest offers on AmInvest trading products and news, please refer to: https://www.aminvest.com/eng/Pages/home.aspx

Tel: +603 2036 1800 / +603 2032 2888
Fax: +603 2031 5210
Email: enquiries@aminvest.com

Office Hours
Monday to Thursday: 8:45am – 5:45pm
Friday: 8:45am – 5:00pm
(GMT +08:00 Malaysia)

Investment Highlights

  • We maintain our HOLD recommendation on Petronas Chemicals Group (PChem) with unchanged forecasts and fair value of RM6.10/share pegged to an FY20F EV/EBITDA of 8.3x, which represents 1 standard deviation below its 3-year average of 8.8x.
  • We maintain our forecasts following a teleconference briefing to investors yesterday. These are the key takeaways:
  • PChem’s 4QFY19 plant utilisation rebounded 8 percentage points (ppt) QoQ to 89% with the completion of 6 turnaround activities (TAs) in Sabah and Kerteh – PC Fertiliser Sabah, PC Olefins, PV Glycols, PC Derivatives, PC LDPE and PC Ammonia – mostly in 3QFY19. This drove production volume up by 9%, which together with carried forward inventory from 3QFY19, boosted the group’s 4QFY19 revenue by 15% QoQ.
  • The higher cost inventory, which was manufactured by the olefin and derivatives segment in 3QFY19, together with 4Q2019 product price contraction on lower demand caused a 10ppt QoQ contraction in the group’s 4QFY19 EBITDA margin to 30%.
  • Management indicated that this higher cost from carried forward inventory accounted for 9%–10% of the group’s 4QFY19 cost of sales. Including a RM31mil stock write-down from lower product prices and RM72mil forex loss, PChem’s 4QFY19 net profit fell 39% QoQ to RM340mil.
  • For the fertiliser and methanol division, which underwent only 1 TA in 3QFY19, the main reason for a 6ppt QoQ EBITDA contraction in 4QFY19 stemmed from lower average unit selling price.
  • FY19 average plant utilisation (PU) was flattish YoY at 92%, undergoing 6 plant TAs with similar production volume of 10.4mil tonnes.
  • With a flattish product price outlook over the next 3 months, management expects FY20F PU to be higher than 92% due to low turnaround days, with only units in Gebeng and Labuan plants scheduled to undergo 30–40 day TAs in 1Q2020 and 3QFY20 respectively.
  • While China accounts for 18% of PChem’s sales volume and 15% of revenue in FY19, management has not experienced any order cancellation or delivery delays due to the Wuhan coronavirus (Covid-19) disruption so far. Should the need arise, PChem indicated that these sales can be redirected to other Asian Pacific regions.
  • The group’s 50%-owned petrochemical operation in the Pengerang Integrated Complex is expected to achieve EBITDA breakeven in 2H2020 when the plant reaches full operation amid low polyethylene-naphtha spread currently.
  • PChem currently trades at a fair FY20F EV/EBITDA of 8x, which is slightly below its 3-year average, while its dividend yields are unassuming at 3%.

Source: AmInvest Research - 28 Feb 2020

Related Stocks
Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment